OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Medications and conditions associated with weight loss in patients prescribed semaglutide based on real‐world data
William C. Powell, Xing Song, Yahia Mohamed, et al.
Obesity (2023) Vol. 31, Iss. 10, pp. 2482-2492
Open Access | Times Cited: 14
William C. Powell, Xing Song, Yahia Mohamed, et al.
Obesity (2023) Vol. 31, Iss. 10, pp. 2482-2492
Open Access | Times Cited: 14
Showing 14 citing articles:
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Lauren A. Jones, Daniel I. Brierley
Endocrinology (2025)
Open Access | Times Cited: 2
Lauren A. Jones, Daniel I. Brierley
Endocrinology (2025)
Open Access | Times Cited: 2
One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice
Hamlet Gasoyan, Elizabeth R. Pfoh, Rebecca Schulte, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2433326-e2433326
Open Access | Times Cited: 13
Hamlet Gasoyan, Elizabeth R. Pfoh, Rebecca Schulte, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2433326-e2433326
Open Access | Times Cited: 13
Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study
Amy L. McKenzie, Shaminie J. Athinarayanan
Diabetes Therapy (2024) Vol. 15, Iss. 4, pp. 843-853
Open Access | Times Cited: 7
Amy L. McKenzie, Shaminie J. Athinarayanan
Diabetes Therapy (2024) Vol. 15, Iss. 4, pp. 843-853
Open Access | Times Cited: 7
Intrapatient Changes in CT-Based Body Composition After Initiation of Semaglutide (Glucagon-Like Peptide-1 Agonist) Therapy
Leslie W. Nelson, Matthew H. Lee, John W. Garrett, et al.
American Journal of Roentgenology (2024) Vol. 223, Iss. 6
Closed Access | Times Cited: 7
Leslie W. Nelson, Matthew H. Lee, John W. Garrett, et al.
American Journal of Roentgenology (2024) Vol. 223, Iss. 6
Closed Access | Times Cited: 7
A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data
Yikuan Du, Mengting Zhang, Zhenjie Wang, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 10, pp. 1422-1433
Open Access | Times Cited: 5
Yikuan Du, Mengting Zhang, Zhenjie Wang, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 10, pp. 1422-1433
Open Access | Times Cited: 5
Trends in Obesity Care Among US Adults, 2010–2021
Meghan I. Podolsky, Rafeya Raquib, Katherine Hempstead, et al.
Medical Care (2025)
Closed Access
Meghan I. Podolsky, Rafeya Raquib, Katherine Hempstead, et al.
Medical Care (2025)
Closed Access
Roux-en-Y gastric bypass, adjustable gastric banding, or sleeve gastrectomy for severe obesity (By-Band-Sleeve): a multicentre, open label, three-group, randomised controlled trial
Sally Abbott, Benita Adams, Sanjay Agrawal, et al.
The Lancet Diabetes & Endocrinology (2025)
Open Access
Sally Abbott, Benita Adams, Sanjay Agrawal, et al.
The Lancet Diabetes & Endocrinology (2025)
Open Access
Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP ‐1RA ‐based weight‐loss therapies
Reimar W. Thomsen, Aurélie Mailhac, Julie B. Løhde, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Reimar W. Thomsen, Aurélie Mailhac, Julie B. Løhde, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
What Is Food Noise? A Conceptual Model of Food Cue Reactivity
Daisuke Hayashi Neto, Caitlyn G. Edwards, Jennifer A. Emond, et al.
Nutrients (2023) Vol. 15, Iss. 22, pp. 4809-4809
Open Access | Times Cited: 12
Daisuke Hayashi Neto, Caitlyn G. Edwards, Jennifer A. Emond, et al.
Nutrients (2023) Vol. 15, Iss. 22, pp. 4809-4809
Open Access | Times Cited: 12
Factors Associated With Semaglutide Initiation Among Adults With Obesity
Meghan I. Podolsky, Rafeya Raquib, Paul Shafer, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2455222-e2455222
Open Access
Meghan I. Podolsky, Rafeya Raquib, Paul Shafer, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2455222-e2455222
Open Access
Impact of Anti‐obesity Medication Initiation and Duration on Weight Loss
M. Rami Bailony, P Espinoza, Harun Yüksel, et al.
Obesity Science & Practice (2025) Vol. 11, Iss. 2
Open Access
M. Rami Bailony, P Espinoza, Harun Yüksel, et al.
Obesity Science & Practice (2025) Vol. 11, Iss. 2
Open Access
Influence of BMI-associated genetic variants and metabolic risk factors on weight loss with semaglutide: a longitudinal clinico-genomic cohort study
Matthew E. Levy, Natalie Telis, Kelly M. Schiabor Barrett, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Matthew E. Levy, Natalie Telis, Kelly M. Schiabor Barrett, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes
Erik Stenberg, Yang Cao, Johan Ottosson, et al.
Diabetes Obesity and Metabolism (2024)
Open Access
Erik Stenberg, Yang Cao, Johan Ottosson, et al.
Diabetes Obesity and Metabolism (2024)
Open Access
Weight Recurrence After Sleeve Gastrectomy
Abdulaziz Karam Ali, Amin Andalib
(2024), pp. 577-592
Closed Access
Abdulaziz Karam Ali, Amin Andalib
(2024), pp. 577-592
Closed Access
